Brewin Dolphin Wealth Management’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
OCBV
Brewin Dolphin Wealth Management's RMD Position: Q2 2022 in Review
Brewin Dolphin Wealth Management reduced its ResMed (RMD) stake by 1.9% in Q2 2022, selling an estimated $79.2K and leaving 18,875 shares worth $3.96M. The position accounts for 0.43% of the portfolio, ranked #40.
Brewin Dolphin Wealth Management first reported a position in RMD in Q3 2017 and has held it in 20 quarters since. The position peaked at $5.28M in Q3 2021. 676 funds tracked by Wall St. Rank hold RMD as of Q2 2022.
- Brewin Dolphin Wealth Management held 18,875 shares of ResMed worth $3.96M as of Q2 2022.
- Brewin Dolphin Wealth Management sold 372 ResMed shares in Q2 2022, an estimated $79.2K.
- ResMed made up 0.43% of Brewin Dolphin Wealth Management's portfolio in Q2 2022, its #40 holding.
- Brewin Dolphin Wealth Management first reported a position in ResMed in Q3 2017 and has held it in 20 quarters since.
- Brewin Dolphin Wealth Management's ResMed position peaked at $5.28M in Q3 2021.
- 676 funds tracked by Wall St. Rank held ResMed as of Q2 2022.
Based on Brewin Dolphin Wealth Management's 13F filing for Q2 2022, filed 14 Nov 2022.